The role of progranulin in ischemic heart disease and its related risk factors

Area of Science:

• Cardiovascular Biology
• Endocrinology
• Molecular Medicine

Background:

• Cardiovascular disease, particularly ischemic heart disease, is a leading global cause of mortality.
• Obesity and associated disorders significantly contribute to cardiovascular events.
• Adipose tissue functions as an endocrine organ, secreting adipokines crucial for cardiac function.

Purpose of the Study:

• To elucidate the multifaceted role of progranulin (PGRN) in ischemic heart disease.
• To explore PGRN's interactions with cardiovascular risk factors like metabolic syndrome and type two diabetes.

Main Methods:

• This review synthesizes existing research on progranulin's function in cardiovascular health and disease.
• Analysis of progranulin's molecular mechanisms, including its interaction with apo-lipoprotein A-1 and effects on endothelial function.

Main Results:

• Progranulin exhibits anti-inflammatory effects in the vascular endothelium, potentially stabilizing atherosclerotic plaques.
• It may offer athero-protection by increasing nitric oxide levels, enhancing reverse cholesterol transport, and exerting antithrombotic effects.
• Conversely, progranulin can display pro-inflammatory actions, particularly in the context of metabolic syndrome and type two diabetes.

Conclusions:

• Progranulin presents a complex profile in ischemic heart disease, with both protective and detrimental roles.
• Understanding these dual actions is critical for developing targeted therapeutic strategies for cardiovascular disease.
• Further research is warranted to fully delineate progranulin's impact in various cardiovascular disease states.